1 / 41

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease. General Data:. Name: Baby Boy G Neonate born of a 22 year old primigravida. History of the Present Illness. Initial prenatal check-up 6 th month of pregnancy at local health center CBC, urinalysis normal

reuel
Download Presentation

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

  2. General Data: • Name: Baby Boy G • Neonate • born of a 22 year old primigravida

  3. History of the Present Illness • Initial prenatal check-up • 6th month of pregnancy at local health center • CBC, urinalysis normal • UTZ: single live intrauterine pregnancy, cephalic, good cardiac and somatic activity, 24-25 weeks AOG, rule out hypoplastic right ventricle. • Referred to USTH

  4. HPI • USTH (October 2010) • Fetal 2D- Echocardiogram: hypoplastic Left Ventricle, hypoplastic Mitral Valve, and a patent foramen ovale • (+) Trichomoniasis • 26-27 weeks AOG • Metronidazole 500mg/tab for 7 days • (+) UTI • 37-38 weeks AOG • Cefuroxime 500mg BID for 7 days

  5. HPI • The mother came in our institution for follow up • 3 cm dilated, 70% effaced intact BOW, there was progression of labor alongside with spontaneous rupture of BOW. • Clear, non-foul smelling amniotic fluid • Repeat fetal 2D echo was not done due to lack of funds

  6. Maternal History • (-)exposure to radiation • (-) symptoms of viral exanthems • (-) use ofillicit drugs and abortifacients • Non-smoker • Non drinker of alcoholic beverages • (-)hypertension, allergy, thyroid disease, diabetes, asthma, liver disease, or blood dyscrasia • Hep B screening non-reactive • OGCT normal

  7. Family History

  8. Family History • No diabetes, hypertension, allergies • Denies hereditary illnesses

  9. Physical Examination • General Data • live, term, singleton, male, delivered via normal spontaneous delivery • BW 2.75 kg, BL 48 cm • AS 6 and 7 at 5 minutes, MT 38-39 weeks AOG • AGA

  10. Physical Examination on Admission • HR 134 bpm, RR 58 cpm, T 37.2˚C • Blue, pale; some flexion of extremities, good respiratory effort, cyanotic • (-) Rash, (-) birth marks, • (+) Molding, (+) caput succedaneum (-) cephalhematoma • (+) ROR OU, (-) eye discharge, normal set ears, (-) preauricular pits, patent nares, (-) Epstein’s pearls

  11. Physical Examination on Admission • (-) Palpable neck masses, intact clavicle, no crepitations • (-) Chest deformities, symmetrical chest expansion, (-) retractions, clear and equal breath sounds • Adynamicprecordium, regular heart rate and rhythm, grade 1 holosystolic murmur • Globular abdomen, (+) umbilical stump with 2 arteries and 1 vein, (-) organomegaly, (-) palpable masses • Grossly male, bilaterally descended testes, good rugae, patent anus • Femoral pulses full and equal, (-) Barlow, (-) Ortolani • Straight spine, (-) sacral dimpling, (-) tuft of hair • (+) Moro, grasp, rooting, plantar, and sucking reflexes

  12. APPROACH TO DIAGNOSIS OF A PATIENT PRESENTING WITH CYANOSIS AT BIRTH

  13. Indicators that heart disease may exist • Cyanosis • Cardiomegaly (Radiologic or Pericardial bulge) • Pathologic heart murmur • Tachypnea or overt respiratory distress (dyspnea) • Sweating especially during feeding • Increased or decreased pulses • Failure to thrive

  14. Classification of Congenital Heart Diseases A) Acyanotic B) Cyanotic

  15. Major Considerations • Is there a shunt (LR or RL) • Is there obstruction to inflow or outflow • Abnormal heart valves • Abnormal connections of great vessels • Combination

  16. Subgroups of Acyanotic Diseases • Shunt anomalies • Valvular defects • Obstructive lesions • Inflow anomalies • Primary myocardial diseases

  17. Shunt Anomalies • L  R shunt • Increased pulmonary blood flow • Increased pulmonary vascular arterial markings on chest Xray • ASD, VSD, PDA

  18. Obstructive Lesion • Discrepancy in amplitude of the peripheral pulses • Coarctation of the Aorta

  19. Inflow Anomalies • Increased pulmonary venous markings on chest Xray • No murmur • Cor Triatriatum, Pulmonary vein stenosis

  20. Valvular Defects • Stenosis or regurgitant • Characteristic murmur • AS, AR, PS, PR, MS, MR, TS, TR

  21. Primary Myocardial Diseases • No murmur • Disparity between cardiac size and pulmonary vascular markings • Glycogen storage disease • Cardiomyopathy

  22. Hemodynamic Consequences A) Volume (Diastolic) overload B) Pressure (Systolic) overload

  23. ASD Hemodynamic Consequence Diastolic overload of RV

  24. VSD • Hemodynamic Consequence • MODERATE SIZE • Volume overload of LV • LARGE SIZE • Volume overload of LV • Pressure overload of RV

  25. Cyanotic Heart Disease • Cyanotic heart disease exist when one defect or association of defects allow the mixture of saturated and de-saturated blood to reach the systemic circulation

  26. Do you suspect that patient is Cyanotic? • When in doubt • Clubbing • CBC • Hyperoxia test

  27. Hyperoxia Test • Hyperoxia test is considered positive for intracardiac shunting if PO2 < 150 mmHg (torr) after 10 minutes of 100% fiO2

  28. PVA / IVS • Hemodynamic Consequence • Pressure overload of RV

  29. PVA / VSD • Hemodynamic Consequence • Pressure overload of RV

  30. PDA Dependent Pulmonary Circulation • Pulmonary valve atresia (PVA) with intact interventricular septum • Other lesions with accompanying PVA

  31. Approach to diagnosis

  32. Chest x-ray

  33. Causes of Cyanosis

  34. Pulmonary Vascular MarkingsDecreased: Cyanotic

  35. Second Heart Sound (S2)

  36. Cardiac Work-Up • EKG • Chest Xray • 2D echocardiography (TTE, TEE, ICE, IVUS) • Cardiac catheterization • CT angiography, cardiac MRI

  37. PLACE THE: • ECG • 2-D ECHO

  38. Modalities of Management • Pharmacologic • Catheter based therapy • Surgical

  39. Pharmacologic • digoxin, diuretics, inotropes (pressor), vasodilators • Prostaglandin

  40. Catheter Based Therapy (DI KO PA ALAM ITO, EXAMPLES LANG TO) • Balloon atrioseptostomy (Rashkind) • Balloon valvuloplasty • Balloon angioplasty • Delivery of occlusion devices • Radio frequency ablation

  41. Surgical (DI KO PA ALAM ITO, EXAMPLES LANG TO) • Shunts like Modified Blalock-Taussig • PA band • Complete repair • Glenn, Fontan • Norwood • Jatene, Mustard, Senning

More Related